Clinical Trial Update: Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intestinal low-dose radiotherapy combined with immunotherapy for immune-resistant metastatic malignant solid tumors; recruitment is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Esophageal Cancer
• Lung Cancer

Snippet

Sponsor: Chuangzhen Chen | Conditions: Radiotherapy, Metastatic Solid Cancers | Phase 2 | Status: RECRUITING